Flow cytometric analysis of Mouse CD38 expression on BALB/c mouse splenocytes. BALB/c mouse splenocytes were stained with Brilliant Violet 421™ Rat Anti-Mouse CD3 Antibody and either PE Rat IgG2a, κ Isotype Control (Left panel) or PE Rat Anti-Mouse CD38 Antibody (Right panel) at 5 μl/test. Total viable cells, as determined by Fixable Viability Dye 515 (S0D0013), were used for analysis. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
PE Rat Anti-Mouse CD38 Antibody (S-R549)
PE Rat Anti-Mouse CD38 Antibody (S-R549)
Price:
Regular price
$66.00 SGD
Regular price
Sale price
$66.00 SGD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Rat |
| Antigen | CD38 |
| Synonyms | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; 2'-phospho-ADP-ribosyl cyclase; 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase; 2'-phospho-cyclic-ADP-ribose transferase; ADP-ribosyl cyclase 1 (ADPRC 1); Cyclic ADP-ribose hydrolase 1 (cADPR hydrolase 1); Cd38 |
| Location | Membrane |
| Accession | P56528 |
| Clone Number | S-R549 |
| Antibody Type | Rat mAb |
| Isotype | IgG2a,k |
| Application | FCM |
| Reactivity | Ms |
| Positive Sample | BALB/c mouse splenocytes |
| Purification | Protein G |
| Concentration | 0.2 mg/ml |
| Conjugation | PE |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 5μl per million cells in 100μl volume | Ms |
Background
CD38 is a multifunctional type II transmembrane glycoprotein expressed on immune cells and in various tissues, acting both as a receptor and an enzyme that converts NAD⁺ into cyclic ADP-ribose and ADP-ribose to regulate intracellular calcium signaling, immune cell activation, proliferation, and migration, and is also a key therapeutic target in multiple myeloma due to its high expression on malignant plasma cells and its role in modulating NAD⁺ levels linked to aging and metabolic processes.
Picture
Picture
FC
